22-41170591-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001429.4(EP300):​c.4452+20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.286 in 1,609,458 control chromosomes in the GnomAD database, including 71,782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5529 hom., cov: 31)
Exomes 𝑓: 0.29 ( 66253 hom. )

Consequence

EP300
NM_001429.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.157

Publications

18 publications found
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300-AS1 (HGNC:50504): (EP300 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-41170591-C-T is Benign according to our data. Variant chr22-41170591-C-T is described in ClinVar as Benign. ClinVar VariationId is 93741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001429.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EP300
NM_001429.4
MANE Select
c.4452+20C>T
intron
N/ANP_001420.2
EP300
NM_001362843.2
c.4374+20C>T
intron
N/ANP_001349772.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EP300
ENST00000263253.9
TSL:1 MANE Select
c.4452+20C>T
intron
N/AENSP00000263253.7
EP300
ENST00000715703.1
c.4452+20C>T
intron
N/AENSP00000520505.1
EP300
ENST00000674155.1
c.4374+20C>T
intron
N/AENSP00000501078.1

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37605
AN:
151180
Hom.:
5518
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.124
Gnomad AMI
AF:
0.428
Gnomad AMR
AF:
0.425
Gnomad ASJ
AF:
0.318
Gnomad EAS
AF:
0.0569
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.316
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.274
Gnomad OTH
AF:
0.272
GnomAD2 exomes
AF:
0.314
AC:
78725
AN:
250960
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.121
Gnomad AMR exome
AF:
0.600
Gnomad ASJ exome
AF:
0.324
Gnomad EAS exome
AF:
0.0614
Gnomad FIN exome
AF:
0.315
Gnomad NFE exome
AF:
0.278
Gnomad OTH exome
AF:
0.330
GnomAD4 exome
AF:
0.290
AC:
422738
AN:
1458168
Hom.:
66253
Cov.:
33
AF XY:
0.292
AC XY:
211754
AN XY:
725564
show subpopulations
African (AFR)
AF:
0.114
AC:
3794
AN:
33416
American (AMR)
AF:
0.580
AC:
25892
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
8436
AN:
26078
East Asian (EAS)
AF:
0.0412
AC:
1630
AN:
39566
South Asian (SAS)
AF:
0.371
AC:
31954
AN:
86168
European-Finnish (FIN)
AF:
0.320
AC:
17037
AN:
53244
Middle Eastern (MID)
AF:
0.289
AC:
1656
AN:
5732
European-Non Finnish (NFE)
AF:
0.284
AC:
315206
AN:
1109072
Other (OTH)
AF:
0.285
AC:
17133
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
13553
27105
40658
54210
67763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10592
21184
31776
42368
52960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.249
AC:
37632
AN:
151290
Hom.:
5529
Cov.:
31
AF XY:
0.256
AC XY:
18925
AN XY:
73826
show subpopulations
African (AFR)
AF:
0.124
AC:
5100
AN:
41214
American (AMR)
AF:
0.426
AC:
6450
AN:
15138
Ashkenazi Jewish (ASJ)
AF:
0.318
AC:
1103
AN:
3472
East Asian (EAS)
AF:
0.0569
AC:
294
AN:
5168
South Asian (SAS)
AF:
0.371
AC:
1780
AN:
4798
European-Finnish (FIN)
AF:
0.316
AC:
3255
AN:
10294
Middle Eastern (MID)
AF:
0.240
AC:
70
AN:
292
European-Non Finnish (NFE)
AF:
0.274
AC:
18624
AN:
67900
Other (OTH)
AF:
0.269
AC:
566
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1332
2664
3995
5327
6659
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.266
Hom.:
2135
Bravo
AF:
0.255
Asia WGS
AF:
0.178
AC:
621
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Menke-Hennekam syndrome 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.8
DANN
Benign
0.26
PhyloP100
-0.16
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6002271; hg19: chr22-41566595; COSMIC: COSV54331663; COSMIC: COSV54331663; API